{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-269986","form_type":"8-K","ticker":"BIOA","cik":"0001709941","company_name":"BioAge Labs, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.227550+00:00","generated_at":"2026-05-16T23:49:48.895399+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioAge Q3 net loss $20.2M; first participant dosed in BGE-102 Phase 1 trial","bullets":["Net loss of $20.2M ($0.56 EPS) vs $23.4M ($6.70) in Q3 2024; collaboration revenue $2.1M from Novartis deal.","Cash, equivalents, and marketable securities $295.9M as of Sept 30, 2025, expected to fund operations through 2029.","First participant dosed in Phase 1 trial of oral NLRP3 inhibitor BGE-102; initial SAD data expected by year-end 2025.","Oral and parenteral APJ agonist programs on track for IND submissions in 2026; U.S. provisional patent filed May 2025.","Partnerships with Novartis and Lilly advancing as expected."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-269986","json":"https://secwatch.observer/filing/0001193125-25-269986.json","markdown":"https://secwatch.observer/filing/0001193125-25-269986.md","text":"https://secwatch.observer/filing/0001193125-25-269986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1709941/000119312525269986/0001193125-25-269986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1709941/000119312525269986/bioa-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:49:48.895399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}